文献速递骨显像与常规 SPECT放射性药物与辐射防护

输血相关含铁血黄素沉着致脾脏弥漫性摄取的骨显像与MRI对照

Diffuse Splenic Uptake on 99m Tc MDP Bone Scintigraphy Secondary to Transfusion-Related Hemosiderosis : Correlation With MRI Findings.
PubMed 文献 · Clin Nucl Med · 2026-06-18

一例70岁乳腺癌女性,因治疗后骨髓转移所致难治性贫血多次输血,实验室检查AST 50 U/L、ALT 115 U/L。99mTc MDP骨显像示脾脏弥漫性浓聚,增强CT未见脾钙化或梗死,MRI示脾、肝T2显著低信号,提示输血相关继发性含铁血黄素沉着。

要点

  • 骨显像脾弥漫性摄取需考虑铁过载可能
  • 增强CT无脾钙化或梗死时,MRI有助于鉴别
  • MRI脾肝T2低信号支持继发性含铁血黄素沉着

核心结论

  • 骨显像发现脾脏弥漫性摄取时,应将铁过载纳入考虑。

研究设计与样本

  • 个案报道:1例70岁女性乳腺癌患者,因治疗后骨髓转移所致难治性贫血多次输血。
  • 影像对照:99mTc MDP骨显像与增强CT、MRI结果对照。

主要发现

  • 99mTc MDP骨显像示脾脏弥漫性浓聚。
  • 增强CT未见脾钙化或梗死。
  • MRI示脾、肝T2显著低信号,未见脾局灶性病变。

关键数值与推荐

  • 实验室检查:AST 50 U/L、ALT 115 U/L。

临床怎么用

  • 骨显像见脾弥漫性摄取时,结合输血史并考虑MRI评估铁过载。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 70-year-old woman with a past medical history of breast cancer is undergoing surveillance. She also had a history of repeated blood transfusions for refractory anemia caused by treated marrow metastatic disease. Laboratory tests showed elevated AST (50 U/L) and ALT (115 U/L). 99m Tc MDP bone scintigraphy revealed intense diffuse splenic uptake. No splenic calcifications or infarcts were found on contrast-enhanced CT. MRI demonstrated signal dropout on in-phase sequences and marked T2 hypointensity of the spleen and liver, without focal splenic lesions, suggesting transfusion-related secondary hemosiderosis. Iron overload should be considered when diffuse splenic uptake is observed on bone scintigraphy.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mohamed OAE, ElSayes KM, Morton K, et al. Diffuse Splenic Uptake on 99m Tc MDP Bone Scintigraphy Secondary to Transfusion-Related Hemosiderosis : Correlation With MRI Findings. Clin Nucl Med. 2026. PMID: 42307418. doi:10.1097/RLU.0000000000006580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。